EVENT
Visit to Bio2Q by Dr. Hitoshi Nakagama, President of the Japan Agency for Medical Research and Development (AMED)
October 7, 2025
On September 22, 2025, Dr. Hitoshi Nakagama, President of the Japan Agency for Medical Research and Development (AMED), visited Bio2Q.
Administrative Director Oltea Sampetrean and others attended the meeting, introduced Bio2Q, exchanged opinions, and guided a tour of the facilities.
For more details, please see the report on the AMED website.
Visit report by AMED (in Japanese)
SHARE
More Bio2Q News
Newsletter “Bio2Q Connect” (Vol. 2, Issue 11)
We are delighted to share with you Vol. 2, Issue 11 of WPI-Bio2Q Newsletter “Bio2Q Connect”. Major topics of this issue include: The 3...
New Research Internship Student - Ms. Julia Tsanis-Horniblow
Introducing a new Research Internship Student of Bio2Q We are delighted to welcome Ms. Julia Tsanis-Horniblow as a Research Internship Stud...
Six WPI-Bio2Q Researchers Recognized as “Highly Cited Researchers 2025”
Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) is proud to announce that six of our researchers were selected ...
[Publication]Monitoring ferroptosis in vivo: Iron-driven volatile oxidized lipid...
Researchers from Bio2Q and Keio University have developed a noninvasive method to detect ferroptosis by analyzing volatile oxidized lipids i...
New Research Internship Student - Ms. Enya Mistry
Introducing a new Research Internship Student of Bio2Q We are delighted to welcome Ms. Enya Mistry as a Research Internship Student of Bio2...
